Figg WD - Search Results

1

Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay.

Macpherson GR, Ng SS, Forbes SL, Melillo G, Karpova T, McNally J, Conrads TP, Veenstra TD, Martinez A, Cuttitta F, Price DK, Figg WD. Macpherson GR, et al. Among authors: figg wd. Mol Cancer Ther. 2003 Sep;2(9):845-54. Mol Cancer Ther. 2003. PMID: 14555703

2

In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.

Dixon SC, Zalles A, Giordano C, Lush RM, Venzon D, Reed E, Figg WD. Dixon SC, et al. Among authors: figg wd. Cancer Lett. 1997 Feb 26;113(1-2):111-6. doi: 10.1016/s0304-3835(97)04603-x. Cancer Lett. 1997. PMID: 9065809

3

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent.

Bauer KS, Dixon SC, Figg WD. Bauer KS, et al. Among authors: figg wd. Biochem Pharmacol. 1998 Jun 1;55(11):1827-34. doi: 10.1016/s0006-2952(98)00046-x. Biochem Pharmacol. 1998. PMID: 9714301

4

The androgen receptor: genetic considerations in the development and treatment of prostate cancer.

Cude KJ, Dixon SC, Guo Y, Lisella J, Figg WD. Cude KJ, et al. Among authors: figg wd. J Mol Med (Berl). 1999 May;77(5):419-26. doi: 10.1007/s001090050372. J Mol Med (Berl). 1999. PMID: 10426191 Review.

5

Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.

Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD. Bauer KS, et al. Among authors: figg wd. J Pharmacol Exp Ther. 2000 Jan;292(1):31-7. J Pharmacol Exp Ther. 2000. PMID: 10604929

6

UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response.

Kruger EA, Blagosklonny MV, Dixon SC, Figg WD. Kruger EA, et al. Among authors: figg wd. Invasion Metastasis. 1998-1999;18(4):209-18. doi: 10.1159/000024514. Invasion Metastasis. 1998. PMID: 10640907

7

Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.

Kruger EA, Duray PH, Tsokos MG, Venzon DJ, Libutti SK, Dixon SC, Rudek MA, Pluda J, Allegra C, Figg WD. Kruger EA, et al. Among authors: figg wd. Biochem Biophys Res Commun. 2000 Feb 5;268(1):183-91. doi: 10.1006/bbrc.1999.2018. Biochem Biophys Res Commun. 2000. PMID: 10652234

8

Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.

Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK. Berger AC, et al. Among authors: figg wd. Microvasc Res. 2000 Jul;60(1):70-80. doi: 10.1006/mvre.2000.2249. Microvasc Res. 2000. PMID: 10873516

9

Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay.

Krüger EA, Figg WD. Krüger EA, et al. Among authors: figg wd. Clin Cancer Res. 2001 Jul;7(7):1867-72. Clin Cancer Res. 2001. PMID: 11448898

10

The androgen receptor gene and its influence on the development and progression of prostate cancer.

Montgomery JS, Price DK, Figg WD. Montgomery JS, et al. Among authors: figg wd. J Pathol. 2001 Sep;195(2):138-46. doi: 10.1002/1096-9896(200109)195:2<138::AID-PATH961>3.0.CO;2-Y. J Pathol. 2001. PMID: 11592091 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters